Change Agents Corporation. (CHGA) stock
Close on Nov 12, 2026Market cap $18.73MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $18.73M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.86
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$8.98M
- EPS, diluted
- -$5.64
- Book value per share
- $0.64
- Diluted shares
- 16M
Trading
- Previous close
- $0.85
- Open
- $0.87
- Day's range
- $0.85 – $0.94
- Volume
- 10,067
- Average volume (20 days)
- 43,938
- Beta (5 years)
- 0.74
- 52-week range
- $0.69 – $41.60
- RSI (14 days)
- 32.9
- Volatility (1 year)
- 174.2%
- Relative volume
- 0.02×
- WACC
- 8.6%
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CHGA | S&P 500 | Difference | CHGA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -55.3% | -2.7% | −52.6 pts | ||
| 3 months | -79.6% | -1.7% | −77.8 pts | ||
| Year to date | -96.1% | +11.9% | −108.0 pts | ||
| 1 year | -97.7% | +12.0% | −109.6 pts | ||
| 3 years | -99.5% | +78.2% | −177.7 pts | -82.8% | +21.2% |
| 5 years | -100.0% | +73.2% | −173.2 pts | -80.2% | +11.6% |
| 10 years | -100.0% | +309.6% | −409.6 pts | -55.4% | +15.1% |
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Change Agents filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- News
- News
- News
- News
- News
About Change Agents
Services-Computer Programming Services
Avalon GloboCare Corp. is a technology-innovation company operating in two primary business segments: consumer health technology and artificial intelligence content technology. In consumer health, the company distributes the Keto Air breathalyzer, a non-invasive, reusable, FDA-registered device designed to determine nutritional ketosis levels by measuring a user's breath. In its AI content technology segment, the company develops and commercializes an AI-driven short-form video generation platform through its subsidiary, Avalon Quantum AI, LLC. The platform creates automated videos featuring personalized AI avatars that replicate the voice and likeness of content creators. The company directs its commercial sales and services toward content creators, podcasters, marketers, social media influencers, consumers, and wellness initiatives such as law enforcement personnel programs.
Company profile, executives and historyChange Agents stock: common questions
What is Change Agents's stock price?
CHGA closed at $0.94 on Nov 12, 2026, up 10.47% on the day. Over the past 52 weeks it traded between $0.69 and $41.60.
What is Change Agents's market cap?
Change Agents was worth $18.73M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CHGA's P/E ratio?
Change Agents lost money over fiscal 2025 (diluted EPS -$5.64), so it has no meaningful P/E ratio.
Does Change Agents pay a dividend?
No. Change Agents has not paid a cash dividend over the last twelve months.
How has CHGA stock performed over the past year?
Including dividends, CHGA returned -97.7% over the past year, against +12.0% for the S&P 500.
Who are Change Agents's competitors?
Companies most similar to Change Agents by business, industry and size include SVRE, KHOBF, UMEW, SHAZ, BTTC.
See a number that looks wrong?